The National Cancer Institute (NCI) launched the PDX (patient-derived xenografts) Development and Trial Centers Research Network (PDXNet) in September, 2017 to accelerate translational research using PDX datasets.

The PDXNet comprises of six PDX Development and Trial Centers (PDTCs) and the PDX Data Commons and Coordinating Center (PDCCC). The two PDTCs added in 2018 focus exclusively on developing minority PDXs. Collectively, the PDTCs and the PDCCC work together to test and advance multi-agent cancer treatments from PDX studies to human clinical trials.

PDXNet is an inclusive consortia welcoming collaborations in part through funded supplements. Please contact us to discuss how we can work together to advance new cancer treatments.

 
PDXNet 2019 Annual Meeting

PDXNet 2019 Annual Meeting